2025年10月29日，毓恬冠佳(301173.SZ)发布2025年第三季报。截至2025年10月28日，共有9个机构投资 者披露持有毓恬冠佳A股股份，合计持股量达5191.80万股，占毓恬冠佳总股本的59.11%。其中，机构 投资者包括上海玉素实业有限责任公司、上海上汽恒旭投资管理有限公司-嘉兴隽通股权投资合伙企业 (有限合伙)、京津冀产业协同发展投资基金(有限合伙)、上海崧毓煌企业管理咨询合伙企业(有限合伙)、 南方工业资产管理有限责任公司、广州盈蓬私募基金管理有限公司-广东广祺柒号股权投资合伙企业(有 限合伙)、上海南虹桥投资管理有限公司-嘉兴虹佳股权投资合伙企业(有限合伙)、中国建设银行股份有 限公司-中欧悦享生活混合型证券投资基金、香港中央结算有限公司，机构投资者合计持股比例达 59.11%。相较于上一季度，机构持股比例合计上涨了0.33个百分点。 公募基金方面，本期较上一期持股增加的公募基金共计1个，即中欧悦享生活混合A，持股增加占比达 0.46%。本期较上一季未再披露的公募基金共计1976个，主要包括国金量化多因子A、国金量化精选 A、国金中证A500指数增强A、国金智享量化选股混合A、圆信永丰 ...

Core Viewpoint - Luyuan Pharmaceutical (002788.SZ) reported its Q3 2025 results, highlighting a total institutional ownership of 145 million shares, representing 37.29% of the company's total equity, with a slight decrease in institutional holding compared to the previous quarter [1] Institutional Ownership - As of October 26, 2025, three institutional investors disclosed their holdings in Luyuan Pharmaceutical, with a combined shareholding of 145 million shares, accounting for 37.29% of the total equity [1] - The institutional ownership ratio decreased by 0.12 percentage points compared to the previous quarter [1] - The institutional investors include Xiamen Meidiken Technology Co., Ltd., Xiamen Santai Technology Co., Ltd., and China Merchants Fund Management Co., Ltd. - Social Security Fund 1903 Combination [1] Public Fund Disclosure - In this reporting period, 44 public funds were disclosed, including notable funds such as Guojin Quantitative Multi-Factor A, Everbright Prudential Quantitative Stock A, and Guojin CSI A500 Index Enhanced A [1] Social Security Fund - One new social security fund disclosed its holdings in Luyuan Pharmaceutical, specifically the China Merchants Fund Management Co., Ltd. - Social Security Fund 1903 Combination [1] Foreign Investment - The report indicates that there was a lack of new disclosures from foreign institutions, with Barclays Bank PLC being the only foreign institution not disclosing holdings compared to the previous quarter [1]